Advertisement

Platelet von Willebrand Factor — Collagen Binding Activity and Ristocetin Cofactor Activity: A Comparison of Methods Able to Differentiate von Willebrand Disease Types I and II (Preliminary Results)

  • K. B. Thomas
  • S. C. Choong
  • U. Jessat
  • B. Zieger
  • U. Budde
  • E. P. Tune
  • A. Grohmann
  • A. H. Sutor
Conference paper

Abstract

von Willebrand disease (vWD) is the most common inherited bleeding disorder. By laboratory analysis vWD affects approximately 1% of the general population. Clinically significant vWD occurs in approximately 125 per million population [1,2]. The disease is caused by the quantitative absence or qualitative alteration of von Willebrand Factor (vWF) — a multimeric glycoprotein present in plasma and platelets, synthesised in endothelial cells and in megakaryocytes [3]. Classification of patients with vWD into subtypes is important for the correct choice of treatment as well as for genetic counselling. The patient’s clinical symptoms, heredity patterns and the laboratory results of vWF analysis vary depending on the vWD subtype [4]. The bleeding symptoms in patients with vWD are believed to be due to an abnormal interaction of vWF with the subendothelium and/or with the platelets during formation of the haemostatic plug, illustrating the main physiological roles of vWF during normal haemostasis [5–7].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sadler EJ (1991) von Willebrand Factor. Minireview. J Biol Chem 266: 22777–22780Google Scholar
  2. 2.
    Abshire TC, Broxson EH, Tucker EL, Giroux DS, Werner EJ (1993) Prevalence of von Willebrand disease in children: a multiethic study. Thromb Haemost 69: 1183 (Abst)Google Scholar
  3. 3.
    Wagner DD (1990) Cell biology of von Willebrand factor. Annu Rev Cell Biol 6: 217–246PubMedCrossRefGoogle Scholar
  4. 4.
    Ginsburg D, Bowie EJW (1992) Molecular genetics of von Willebrand disease. Blood 79: 2507–2519PubMedGoogle Scholar
  5. 5.
    Mohri H, Fujimura Y, Shima M, Yoshioka A, Houghten RA; Ruggeri ZM, Zimmerman TS (1988) Structure of the von Willebrand factor domain interacting with glycoprotein lb. J Biol Chem 263: 17901–17904PubMedGoogle Scholar
  6. 6.
    Ruggeri ZM, Ware J (1992) The structure and function of von Willebrand factor. Thromb Haemost 67: 594–599PubMedGoogle Scholar
  7. 7.
    Meyer D, Girma JP (1993) von Willebrand factor: Structure and function. Thromb Haemost 70: 99–104Google Scholar
  8. 8.
    Santoro SA (1981) Adsorption of von Willebrand factor/factor VIII by the genetically distinct interstitial collagens. Thromb Res 21: 689–693PubMedCrossRefGoogle Scholar
  9. 9.
    Roth GJ, Titani K, Hoyer LW, Hickey MJ (1986) Localization of binding sites within human von Willebrand factor for monomeric type III collagen. Biochemistry 25: 8357–8361PubMedCrossRefGoogle Scholar
  10. 10.
    Kalafatis M, Takahashi Y, Girma JP, Meyer D (1987) Localization of a collagen-interactive domain of human von Willebrand factor between amino acid residues Gly911 and Glu 1365. Blood 70: 1577–1583PubMedGoogle Scholar
  11. 11.
    Pared FI, Niiya K, McPherson JM, Ruggeri ZM (1987) Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen. J Biol Chem 262: 13835–13841Google Scholar
  12. 12.
    Aihara M, Kimura A, Chiba Y, Yoshida Y (1988) Plasma Collagen Cofactor Correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time. Thromb Haemost 59: 485–490PubMedGoogle Scholar
  13. 13.
    Kessler CM, Floyd CM, Frantz SC, Orthner C (1990) Critical role of the carbohydrate moiety in human von Willebrand factor protein for the interactions with type I collagen. Thromb Res 57: 59–76PubMedCrossRefGoogle Scholar
  14. 14.
    Rand JH, Nayana DP, Schwartz E, Sheng-Li Z, Potter BJ (1991) 150–kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen. J Clin Invest 88: 253–259Google Scholar
  15. 15.
    Sixma JJ, Schiphorst ME, Verweij CL, Pannekoek H (1991) Effect of deletion of the A1–domain of von Willebrand factor on its binding to heparin, to collagen and to platelets in the presence of ristocetin. Eur J Biochem 196: 369–375PubMedCrossRefGoogle Scholar
  16. 16.
    Brown JE, Bosak JO (1986) An ELISA test for the binding of von Willebrand antigen to collagen. Thromb Res 43: 303–311PubMedCrossRefGoogle Scholar
  17. 17.
    Duggan MJ, DiMichele DM, Christian MJ, Fink LM, Hathaway WE (1987) Collagen- binding of von Willebrand’s factor antigen in the classification of von Willebrand’s disease. Am J Clin Pathol 88: 97–102PubMedGoogle Scholar
  18. 18.
    Gilchrist M, Stewart MW, Etches WS, Gordon PA (1990) Rapid diagnosis of von Wille-brands disease using ELISA technology. Thromb Res 57: 659–664PubMedCrossRefGoogle Scholar
  19. 19.
    Favaloro EJ, Grispo L, Exner T, Koutts J (1991) Development of a simple collagen based ELISA assay aids in the diagnosis of, and permits sensitive discrimination between type I and type II, von Willebrand’s disease. Blood Coagul Fibrinolysis 2: 285–291PubMedCrossRefGoogle Scholar
  20. 20.
    Choong SC, Thomas KB, Tune EP, Collicut M, Firkin BG (1992) Analysis of human von Willebrand factor (vWF) in a routine laboratory. 24th Congress of the International Society of Haematology. London, 1992, Blackwell Scientific Publications, abstract 490Google Scholar
  21. 21.
    Cejka J (1982) Enzyme immunoassay for VHI-related antigen. Clin Chem 28: 1356–1358PubMedGoogle Scholar
  22. 22.
    Thomas KB, Howard MA, Koutts J, Firkin BG (1982) Simplified immunoradiometric assay for factor VIII coagulant antigen. Br J Haematol 51: 47–57PubMedCrossRefGoogle Scholar
  23. 23.
    Thomas KB, Howard MA, Salem HH, Firkin BG (1983) Fast migrating protein, immunochemically related to human factor VIII, studied by crossed immunoelectrophoresis in agarose. Br J Haematol 54: 221–231PubMedCrossRefGoogle Scholar
  24. 24.
    Macfarlane DE, Stibbe J, Kriby EP, Zucker MB, Grant R, McPherson J (1975) A method for assaying von Willebrand factor (ristocetin cofactor). Thrombosis et Diathesis Haemorrhagica 34: 306–308PubMedGoogle Scholar
  25. 25.
    Raines G, Aumann H, Sykes S, Street A (1990) Multimeric analysis of von Willebrand factor by molecular sieving electrophoresis in sodium dodecyl sulphate agarose gel. Thromb Res 60: 201–212PubMedCrossRefGoogle Scholar
  26. 26.
    Kessler CM, Floyd CM, Rick ME, Krizek DM, Lee SL, Gralnick HR (1984) Collagen- Factor VHI/von Willebrand factor protein interaction. Blood 63: 1291–1298PubMedGoogle Scholar
  27. 27.
    Bockenstedt P, McDonagh J, Handin RI (1986) Binding and covalent cross-linking of purified von Willebrand factor to native monomeric collagen. J Clin Invest 78: 551–556PubMedCrossRefGoogle Scholar
  28. 28.
    Fitzsimmons CM, Cockburn CG, Hornsey V, Prowse CV, Barnes MJ (1988) Interaction of von Willebrand factor (vWF) with collagen. Thromb Haemost 59: 186–192PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1994

Authors and Affiliations

  • K. B. Thomas
  • S. C. Choong
  • U. Jessat
  • B. Zieger
  • U. Budde
  • E. P. Tune
  • A. Grohmann
  • A. H. Sutor

There are no affiliations available

Personalised recommendations